InterAct Consortium United Kingdom (UK)
Research
Date range: 1 November 2020 - 31 October 2021
Research collaboration: InterAct Consortium is a research collaboration whose article contributions are accrued to its participating partner institutions.
Relationships
Partner Institutions
InterAct Consortium is a research collaboration whose article contributions are accrued to its participating partner institutions below.
- Aalborg University Hospital
- Andalusian School of Public Health (EASP), UGR
- Azienda Ospedaliera Civile M.P. Arezzo
- Catalan Institute of Oncology (ICO)
- Danish Cancer Society
- German Cancer Research Center in the Helmholtz Association (DKFZ)
- German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE)
- Healthcare Research Institute of Navarre (IdiSNA)
- Imperial College London (ICL)
- India Diabetes Research Foundation (IDRF)
- Institute for Scientific Interchange (ISI)
- Institute for the Study and Prevention of Cancer (ISPRO)
- Lund University (LU)
- MRC Epidemiology Unit, University of Cambridge
- National Cancer Institute of Milan
- National Institute for Health and Medical Research (INSERM)
- National Institute for Public Health and the Environment (RIVM), VWS
- Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM)
- Steno Diabetes Center A/S
- University Hospital of Umeå (NUS)
- University Medical Center Utrecht (UMC Utrecht)
- University of Eastern Finland (UEF)
- University of Helsinki
- University of Naples Federico II (UNINA)
- University of Oxford
- WHO International Agency for Research on Cancer (IARC)
- Wageningen University & Research (WUR)
- Wellcome Sanger Institute